These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1507584

  • 1. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
    Rhim BY, Lee WS, Hong KW.
    Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR, Li YQ, Wyse DG.
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract] [Full Text] [Related]

  • 3. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
    la Rochelle CD, Richard V, Dubois-Randé JL, Roupie E, Giudicelli JF, Hittinger L, Berdeaux A.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
    [Abstract] [Full Text] [Related]

  • 4. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K, Asano M, Matsuda T, Imaizumi Y, Watanabe M.
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [Abstract] [Full Text] [Related]

  • 5. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH.
    Pflugers Arch; 1989 May; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract] [Full Text] [Related]

  • 6. The effect of intracavernous injection of potassium channel openers in monkeys and dogs.
    Trigo-Rocha F, Donatucci CF, Hsu GL, Nunes L, Lue TF, Tanagho EA.
    Int J Impot Res; 1995 Mar; 7(1):41-8. PubMed ID: 7670592
    [Abstract] [Full Text] [Related]

  • 7. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
    Wu Y, Fang D.
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):180-3. PubMed ID: 1319810
    [No Abstract] [Full Text] [Related]

  • 8. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N, Zhang H, Weir B.
    Biochem Biophys Res Commun; 1991 Nov 27; 181(1):172-8. PubMed ID: 1958186
    [Abstract] [Full Text] [Related]

  • 9. Cromakalim, pinacidil and RP 49356 activate a tolbutamide-sensitive K+ conductance in human skeletal muscle fibres.
    Quasthoff S, Spuler A, Lehmann-Horn F, Grafe P.
    Pflugers Arch; 1989 Nov 27; 414 Suppl 1():S179-80. PubMed ID: 2780252
    [No Abstract] [Full Text] [Related]

  • 10. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return.
    Gotanda K, Yokoyama H, Satoh K, Taira N.
    Cardiovasc Drugs Ther; 1989 Aug 27; 3(4):507-15. PubMed ID: 2488102
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR, Toombs CF, Khan SA, Buchanan LV, Cimini MG, Gibson JK, Meisheri KD, Shebuski RJ.
    Pharmacology; 1994 Aug 27; 49(2):86-95. PubMed ID: 7972325
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
    Wahl M, Parsons AA, Schilling L.
    Cardiovasc Res; 1994 Dec 27; 28(12):1803-7. PubMed ID: 7867033
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
    Taylor SG, Arch JR, Bond J, Buckle DR, Shaw DJ, Taylor JF, Ward JS.
    J Pharmacol Exp Ther; 1992 May 27; 261(2):429-37. PubMed ID: 1578358
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of intracellular calcium by potassium channel openers in vascular muscle.
    Erne P, Hermsmeyer K.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec 27; 344(6):706-15. PubMed ID: 1775202
    [Abstract] [Full Text] [Related]

  • 18. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
    Satoh K.
    Nihon Rinsho; 1993 May 27; 51(5):1293-8. PubMed ID: 8331797
    [Abstract] [Full Text] [Related]

  • 19. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH, McCullough JR.
    Am J Physiol; 1993 May 27; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [Abstract] [Full Text] [Related]

  • 20. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec 27; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.